Dental Care Clinics in Vail, AZ Accepting Medicare
3 Dental Care Clinics found. Showing 1 - 3
 Vail Family Dentistry, Pc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 13190 E Colossal Cave Rd Ste 150, Vail, AZ 85641 Phone: 520-762-3236 Fax: 520-762-8058 |
Dentists Of Vail Dentist Medicare: Not Enrolled in Medicare Practice Location: 13410 E. Mary Ann Cleveland Way, Vail, AZ 85641 Phone: 520-316-0613 Fax: 520-399-7794 |
Vail Family Dentistry Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 13190 E Colossal Cave Rd Ste 150, Vail, AZ 85641 Phone: 520-762-3236 Fax: 520-762-8058 |
News Archive
Table salt fluoridation can reduce the prevalence of dental caries
Table salt fluoridation can reduce the prevalence of dental caries up to 84 percent, according to a new book published by the Pan American Health Organization (PAHO), "Promoting Oral Health: The Use of Salt Fluoridation to Prevent Dental Caries".
UCSF receives $20M Sandler Foundation gift for neuroscience research and care
UCSF has received a challenge gift of $20 million from the Sandler Foundation that will provide major support for the university's groundbreaking research and clinical care efforts regarding neurological diseases.
Cigarette smoke inhibits LTA4H enzyme, regulates body's response to inflammation: Study
Cigarette smoke shuts off a key enzyme in airways that regulates the body's response to inflammation, according to findings from the University of Alabama at Birmingham published online today at Science Express.
YM Biosciences to present JAK1/2 inhibiting small molecule and vascular disrupting agent data at Cancer Conference
YM BioSciences Inc., is presenting posters on its JAK1/2 inhibiting small molecule (CYT387) and on its novel vascular disrupting agent (CYT997) at the Lorne Cancer Conference in Lorne, Victoria, Australia. CYT387 is an oral JAK1/2 inhibitor, originating from the seminal discovery of JAK1 and JAK2 kinases by Dr. Andrew Wilks, the founder of Cytopia Limited, now YM Australia. CYT997 is an orally-available agent with dual mechanisms of vascular disruption and cytotoxicity and has the potential to be broadly active against a range of tumor types.
› Verified 1 days ago